Shazamstocks.com Announces Profile Launch of Oramed Pharmaceuticals, Inc.


WELLINGTON, Fla., May 3, 2007 (PRIME NEWSWIRE) -- Ken Weiner, publisher of Shazamstocks.com, today announced profile coverage of Oramed Pharmaceuticals, Inc (OTCBB:ORMP) (FTSE:OJU). The profile is a comprehensive look at the company's growth initiative. You can view the complete profile at http://www.shazamstocks.com/profiles/ormp/index.php.

About Oramed Pharmaceuticals, Inc.:

Oramed Pharmaceuticals Inc. is an Israeli company focused on the development of oral delivery solutions based on proprietary technology. Diabetes is one of the most rapidly growing diseases in the world and is one that requires constant and often unpleasant monitoring and drug therapy regimen. Oramed is currently developing an orally ingestible soft gel insulin capsule for the treatment of diabetes. The Company is also pursuing the development of oral delivery solutions for other drugs and vaccines.

For more information on Oramed Pharmaceuticals please visit our website at www.oramedpharma.com

About Shazamstocks.com

Shazamstocks.com publishes profiles on up and coming publicly traded companies. Shazamstocks.com is one of the nation's top Internet destinations for small cap stock information. To feature your company, please call Ken Weiner, our publisher, at (561) 793-2665 or email editor@shazamstocks.com.

Disclosure: We have been compensated Sixteen Thousand Dollars by a third party, Green Shoe Investments AG. We also own 70,500 shares in the open market.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking information. Statements that are not descriptions of historical facts are forward-looking statements provided under the "safe harbor" protection of the Private Securities Litigation Reform Act of 1995. These statements are made to enable a better understanding of our business, but because these forward-looking statements are subject to many risks, uncertainties, future developments and changes over time, actual results may differ materially from those expressed or implied by such forward-looking statements. Examples of forward-looking statements are statements about anticipated financial or operating results, financial projections, business prospects, future product performance and other matters that are not historical facts. Such statements often include words such as "believes," "expects," "anticipates," "intends," "plans," "estimates" or similar expressions.

These forward-looking statements are based on the information that was currently available to us, and the expectations and assumptions that were deemed reasonable by us, at the time the statements were made. We do not undertake any obligation to update any forward-looking statements in this report or in any of our other communications, except as required by law, and all such forward-looking statements should be read as of the time the statements were made, and with the recognition that these forward-looking statements may not be complete or accurate at a later date.



            

Kontaktdaten